Citius Pharmaceuticals is trading at $0.42, up 5.35%; broader market sentiment may be supportive, but no clear company-specific announcement was found for October 26. - The latest located company news was an October 12 investor-conference notice. - U.S. indexes were higher as oil eased and investors looked ahead to major earnings and the Federal Reserve meeting. - Citius Pharmaceuticals had also gained 8.79% at the October 23 close, following a recent rebound.